REGULATION OF GLUCOCORTICOID RECEPTOR BY PHOSPHORYLATION
REGULATION OF GLUCOCORTICOID RECEPTOR BY PHOSPHORYLATION
批准号:
6498141
负责人:
Michael J. Garabedian
金额:
$33.5万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-01 至 2005-01-31
中文摘要
本提案的总体目标是,
磷酸化调控的分子机制
糖皮质激素受体(GR)活性。 GR是一种依赖于
转录因子几乎在所有组织中表达,但它
显示出调节细胞基因的非凡能力
具体方式。 虽然糖皮质激素是主要的
激活GR转录调节功能的信号,
GR介导的转录活性也受
磷酸化 GR的氨基末端含有
转录激活结构域是磷酸化的四个
在培养的哺乳动物细胞中的主要位点。 有几种激酶
已经确定,在体外磷酸化糖皮质激素受体在确定的
网站. 其中,细胞周期蛋白依赖性激酶(Cdks)
磷酸化丝氨酸232(S232)和丝氨酸(S224),而c-Jun N-
末端激酶(JNK)磷酸化丝氨酸246(S246),
糖原合成酶激酶-3(GSK 3)磷酸化苏氨酸171
(T171)。 这些位点的磷酸化对于GR
功能:S224和S232的丝氨酸至丙氨酸突变减少
GR转录激活,而T171的丙氨酸突变
和S246增加GR转录激活。 因此,GR-
介导的转录活性受到正向调节,
而磷酸化则呈阴性。 我们建议
多种蛋白激酶的磷酸化使GR能够响应
多种细胞外信号。 这种整合能力
磷酸化形式的多种信号允许
GR作用的灵活性,与类固醇结合,
配体,可能是至关重要的协调细胞类型特异性
我们进一步假设,磷酸化
调节GR与蛋白质的相互作用,
转录调控 这一假设将通过以下方式加以解决:
表达Cdk、JNK和GSK 3的激活剂或抑制剂,
在瞬时转染测定中培养的哺乳动物细胞
用于监测GR依赖的转录调节。 在
此外,我们将鉴定和表征蛋白质,
与GR N-末端转录激活结构域相互作用
以磷酸化依赖的方式使用蛋白质相互作用
在酵母中筛选。 获得机械的理解
多个信号通路之间的通信,如所实现的
通过GR及其调节激酶,是至关重要的,
了解GR调节基因表达的机制,
可能会揭示可能的干预点,
糖皮质激素抵抗的新疗法的开发
恶性肿瘤,如乳腺癌和急性淋巴细胞癌
白血病
英文摘要
The overall objectives of this proposal are to characterize the
molecular mechanisms by which phosphorylation regulates
glucocorticoid receptor (GR) activity. GR is a hormone-dependent
transcription factor expressed in virtually all tissues, yet it
displays a remarkable capacity to regulate genes in a cell type-
specific manner. Although glucocorticoids act as the primary
signal in activating GR's transcriptional regulatory functions,
GR-mediated transcriptional activity is also regulated by
phosphorylation. The amino terminus of GR contains a
transcriptional activation domain that is phosphorylated at four
major sites in cultured mammalian cells. Several kinases have
been identified that phosphorylate GR in vitro at the identified
sites. Of these, the cyclin-dependent kinases (Cdks)
phosphorylate serine 232 (S232) and serine (S224), while c-Jun N-
terminal kinase (JNK) phosphorylates serine 246 (S246) and
glycogen synthase kinase-3 (GSK3) phosphorylates threonine 171
(T171). Phosphorylation of these sites is important for GR
function: serine to alanine mutations of S224 and S232 decrease
GR transcriptional activation, whereas alanine mutations of T171
and S246 increase GR transcriptional activation. Thus, GR-
mediated transcriptional activity is regulated both positively
and negatively by phosphorylation. We propose that
phosphorylation by multiple protein kinases enables GR to respond
to diverse extracellular signals. This ability to integrate
multiple signals in the form of phosphorylation permits a
flexibility in GR action that, in conjunction with the steroid
ligands, may be crucial in coordinating the cell type specific
actions of GR. We further hypothesize that phosphorylation
regulates GR's interaction with proteins involved in
transcriptional regulation. This hypothesis will be addressed by
expressing activators or inhibitors of Cdk, JNK and GSK3 in
cultured mammalian cells in transient transfection assays
designed to monitor GR-dependent transcriptional regulation. In
addition, we will identify and characterize proteins that
interact with the GR N-terminal transcriptional activation domain
in a phosphorylation-dependent manner using a protein interaction
screen in yeast. Gaining a mechanistic understanding of the
communication between multiple signaling pathways, as realized
through GR and its regulatory kinases, is fundamental to
understanding the mechanism of GR-regulated gene expression and
may reveal likely points of intervention to be exploited in the
development of new therapies for glucocorticoid-resistant
malignancies, such as breast cancer and acute lymphoblastic
leukemia.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1074/jbc.m110530200
发表时间:
2002-07-19
期刊:
JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子:
4.8
作者:
[Wang, Z, Frederick, J, Garabedian, MJ]
通讯作者:
Garabedian, MJ
DOI:
10.1016/j.coemr.2022.100378
发表时间:
2022-06
期刊:
Current opinion in endocrine and metabolic research
影响因子:
--
作者:
[F. Jeanneteau;L. Coutellier]
通讯作者:
F. Jeanneteau;L. Coutellier
“Protection from MRSA lethality by inhibiting LXRα phosphorylation”
-
批准号:10681027
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2023
-
负责人:Michael J. Garabedian
-
依托单位:
Peptoid conjugates as inhibitors of androgen receptor dimerization and function in enzalutamide-resistant prostate cancer
-
批准号:9815670
-
项目类别:
-
资助金额:$21.68万
-
财政年份:2019
-
负责人:Michael J. Garabedian
-
依托单位:
Glucocorticoid receptor phosphorylation in endocrine adaptation to stress
-
批准号:9883840
-
项目类别:
-
资助金额:$49.54万
-
财政年份:2019
-
负责人:Michael J. Garabedian
-
依托单位:
Targeting the glucocorticoid receptor in enzalutamide resistant prostate cancer
-
批准号:9178221
-
项目类别:
-
资助金额:$18.43万
-
财政年份:2016
-
负责人:Michael J. Garabedian
-
依托单位:
REGULATION OF ANDROGEN RECEPTOR ACTIVITY IN THE PROSTATE
-
批准号:6381890
-
项目类别:
-
资助金额:$28.31万
-
财政年份:2000
-
负责人:Michael J. Garabedian
-
依托单位:
REGULATION OF ANDROGEN RECEPTOR ACTIVITY IN THE PROSTATE
-
批准号:6608814
-
项目类别:
-
资助金额:$30.1万
-
财政年份:2000
-
负责人:Michael J. Garabedian
-
依托单位:
REGULATION OF ANDROGEN RECEPTOR ACTIVITY IN THE PROSTATE
-
批准号:6524272
-
项目类别:
-
资助金额:$29.19万
-
财政年份:2000
-
负责人:Michael J. Garabedian
-
依托单位:
REGULATION OF ANDROGEN RECEPTOR ACTIVITY IN THE PROSTATE
-
批准号:6153870
-
项目类别:
-
资助金额:$26.76万
-
财政年份:2000
-
负责人:Michael J. Garabedian
-
依托单位:
REGULATION OF GLUCOCORTICOID RECEPTOR BY PHOSPHORYLATION
-
批准号:6350717
-
项目类别:
-
资助金额:$32.53万
-
财政年份:1999
-
负责人:Michael J. Garabedian
-
依托单位:
REGULATION OF GLUCOCORTICOID RECEPTOR BY PHOSPHORYLATION
-
批准号:2736871
-
项目类别:
-
资助金额:$29.91万
-
财政年份:1999
-
负责人:Michael J. Garabedian
-
依托单位:
REGULATION OF GLUCOCORTICOID RECEPTOR BY PHOSPHORYLATION
-
批准号:6150653
-
项目类别:
-
资助金额:$29.14万
-
财政年份:1999
-
负责人:Michael J. Garabedian
-
依托单位:
国内基金
海外基金
蒺藜苜蓿细胞周期蛋白依赖性激酶(cyclin-dependent kinase)对根瘤发育的功能研究
-
批准号:31100871
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2011
-
负责人:何恒斌
-
依托单位: